Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

SIMPLE SUMMARY: Pediatric patients with relapsed or refractory acute lymphoblastic leukemia (ALL) or lymphoma (LBL) currently have unsatisfactory outcomes, and novel treatment options are needed. Venetoclax is approved for adult patients with several types of leukemia and is being investigated in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Gibson, Amber, Trabal, Adriana, McCall, David, Khazal, Sajad, Toepfer, Laurie, Bell, Donna H., Roth, Michael, Mahadeo, Kris M., Nunez, Cesar, Short, Nicholas J., DiNardo, Courtney, Konopleva, Marina, Issa, Ghayas C., Ravandi, Farhad, Jain, Nitin, Borthakur, Gautam, Kantarjian, Hagop M., Jabbour, Elias, Cuglievan, Branko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750927/
https://www.ncbi.nlm.nih.gov/pubmed/35008312
http://dx.doi.org/10.3390/cancers14010150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750927/
https://www.ncbi.nlm.nih.gov/pubmed/35008312
http://dx.doi.org/10.3390/cancers14010150

Ejemplares similares